APP and myeloid sarcoma: However, in neurodegenerative diseases, including MS/EAE, some forms of APP and tau proteins may have an immunosuppressive effect, reducing the level of inflammatory cytokines and the degree of paralysis, thus showing unexpected benefits in neuroinflammatory conditions [9,12].